Assessment of the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients

Baldane Suleyman; Celik M; Kebapcilar Levent; Ipekci Suleyman Hilmi; Abusoglu Sedat; Yilmaz Huseyin; Alptekin Husnu

doi:10.2478/enr-2022-0028

Endocrine Regulations (Oct 2022)

Assessment of the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients

Baldane Suleyman,
Celik M,
Kebapcilar Levent,
Ipekci Suleyman Hilmi,
Abusoglu Sedat,
Yilmaz Huseyin,
Alptekin Husnu

Affiliations

Baldane Suleyman: Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Selcuk University, Konya, Turkey
Celik M: Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Selcuk University, Konya, Turkey
Kebapcilar Levent: Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Selcuk University, Konya, Turkey
Ipekci Suleyman Hilmi: Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Selcuk University, Konya, Turkey
Abusoglu Sedat: Department Biochemistry, Faculty of Medicine, Selcuk University, Konya, Turkey
Yilmaz Huseyin: Department of Surgery, Faculty of Medicine, Selcuk University, Konya, Turkey
Alptekin Husnu: Department of Surgery, Faculty of Medicine, Selcuk University, Konya, Turkey

DOI: https://doi.org/10.2478/enr-2022-0028
Journal volume & issue: Vol. 56, no. 4
pp. 265 – 270

Abstract

Read online

Objective. This study was aimed to evaluate the prevalence of Cushing’s syndrome and the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients.

Published in Endocrine Regulations

ISSN: 1336-0329 (Online)
Publisher: Sciendo
Country of publisher: Poland
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
Website: https://sciendo.com/journal/ENR

About the journal

Abstract

Keywords